MA69591B1 - Delftia tsuruhatensis pour réduire ou prévenir la transmission parasite du paludisme et pour prévenir le paludisme - Google Patents

Delftia tsuruhatensis pour réduire ou prévenir la transmission parasite du paludisme et pour prévenir le paludisme

Info

Publication number
MA69591B1
MA69591B1 MA69591A MA69591A MA69591B1 MA 69591 B1 MA69591 B1 MA 69591B1 MA 69591 A MA69591 A MA 69591A MA 69591 A MA69591 A MA 69591A MA 69591 B1 MA69591 B1 MA 69591B1
Authority
MA
Morocco
Prior art keywords
malaria
prevent
reduce
delftia
delftia tsuruhatensis
Prior art date
Application number
MA69591A
Other languages
English (en)
Inventor
Alfonso Mendoza Losana
Janneth RODRIGUES
Original Assignee
Glaxosmithkline Intellectual Property Development Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Intellectual Property Development Limited filed Critical Glaxosmithkline Intellectual Property Development Limited
Publication of MA69591B1 publication Critical patent/MA69591B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P15/00—Biocides for specific purposes not provided for in groups A01P1/00 - A01P13/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P17/00—Pest repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une composition comprenant des bactéries du genre Delftia , spécifiquement une composition comprenant Delftia tsuruhatensis ainsi que les bactéries elle-même pour une utilisations dans la prévention de la transmission du paludisme et des procédés d'utilisation des compositions de l'invention pour réduire la transmission du paludisme et/ou la transmission du paludisme chez les parasites.
MA69591A 2019-07-12 2020-07-10 Delftia tsuruhatensis pour réduire ou prévenir la transmission parasite du paludisme et pour prévenir le paludisme MA69591B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP19382593 2019-07-12
EP19382821 2019-09-24
EP20737037.0A EP3996726B1 (fr) 2019-07-12 2020-07-10 Delftia tsuruhatensis pour réduire ou prévenir la transmission parasite du paludisme et pour prévenir le paludisme
PCT/EP2020/069569 WO2021009050A1 (fr) 2019-07-12 2020-07-10 Réduction de la transmission du paludisme

Publications (1)

Publication Number Publication Date
MA69591B1 true MA69591B1 (fr) 2026-04-30

Family

ID=71515170

Family Applications (1)

Application Number Title Priority Date Filing Date
MA69591A MA69591B1 (fr) 2019-07-12 2020-07-10 Delftia tsuruhatensis pour réduire ou prévenir la transmission parasite du paludisme et pour prévenir le paludisme

Country Status (15)

Country Link
US (1) US20230051209A1 (fr)
EP (1) EP3996726B1 (fr)
JP (1) JP7562631B2 (fr)
KR (1) KR102911972B1 (fr)
CN (1) CN114144512B (fr)
AU (1) AU2020312641B2 (fr)
BR (1) BR112022000314A2 (fr)
CA (1) CA3146236A1 (fr)
ES (1) ES3068341T3 (fr)
HR (1) HRP20260440T1 (fr)
MA (1) MA69591B1 (fr)
PL (1) PL3996726T3 (fr)
RS (1) RS67951B1 (fr)
SM (1) SMT202600163T1 (fr)
WO (1) WO2021009050A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024100131A1 (fr) 2022-11-08 2024-05-16 Glaxosmithkline Intellectual Property Development Limited Réduction de la transmission de maladies portées par un vecteur
CN120091818A (zh) 2022-11-08 2025-06-03 葛兰素史密斯克莱知识产权发展有限公司 用1-甲基-9H-吡啶并[3,4-b]吲哚减少或预防疟疾寄生虫或登革热病毒传播

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100537746C (zh) 2006-10-13 2009-09-09 北京工商大学 具有好氧反硝化性能的戴尔福特菌及其处理废水的方法
CA2749262C (fr) * 2009-01-16 2020-09-22 Sanaria Inc. Plasmodium purifie et compositions de vaccin
CN101993838A (zh) 2010-07-08 2011-03-30 浙江工业大学 具有氯苯胺降解能力的代尔夫特菌h1及其应用
AU2014288309B9 (en) 2013-07-09 2018-04-26 Toray Industries, Inc. Method for producing saccharide solution
CN104531585B (zh) 2014-12-31 2017-03-15 中国水稻研究所 一种戴尔福特菌及其应用

Also Published As

Publication number Publication date
JP2022540643A (ja) 2022-09-16
CN114144512A (zh) 2022-03-04
JP7562631B2 (ja) 2024-10-07
EP3996726A1 (fr) 2022-05-18
BR112022000314A2 (pt) 2022-02-22
CA3146236A1 (fr) 2021-01-21
PL3996726T3 (pl) 2026-06-15
RS67951B1 (sr) 2026-04-30
WO2021009050A1 (fr) 2021-01-21
CN114144512B (zh) 2025-10-10
EP3996726B1 (fr) 2026-02-25
ES3068341T3 (en) 2026-05-29
KR102911972B1 (ko) 2026-01-14
US20230051209A1 (en) 2023-02-16
KR20220034114A (ko) 2022-03-17
AU2020312641B2 (en) 2024-10-17
SMT202600163T1 (it) 2026-05-12
EP3996726C0 (fr) 2026-02-25
HRP20260440T1 (hr) 2026-05-08
AU2020312641A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
MA43186B1 (fr) Anticorps se liant spécifiquement à pd-1 et leurs utilisations
MA52773B1 (fr) Anticorps anti-cd3 et leurs utilisations
MA34753B1 (fr) Compositions et procédés de traitement dans des applications cliniques à large spectre, indifférenciées ou mixtes
MA52545B1 (fr) Anticorps pour radionucléides chélatés
MA43187B1 (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
MA47043B1 (fr) Composés indole carboxamides utiles comme inhibiteurs de kinase
MA40290A1 (fr) Agents immunorégulateurs
WO2019035864A8 (fr) Activateurs de la pyruvate kinase destinés à être utilisés dans le traitement de troubles sanguins
MA34067B1 (fr) Composés à base de complexes de fe(iii) pour le traitement et la prévention des carences en fer et des anémies dues à une carence en fer
TN2010000154A1 (fr) Composition destinee a la regulation du metabolism des lipides
MA29444B1 (fr) Antagonistes npy, preparation et utilisations
FR3044900B1 (fr) Agents nettoyants tensioactifs comportant au moins trois agents conservateurs differents
MA38393A3 (fr) Composés hétéroaryle et utilisations associées
MA54975B1 (fr) Anticorps anti-pcrv qui se lient à pcrv, compositions comprenant des anticorps anti-pcrv, et leurs méthodes d'utilisation
FR3029790B1 (fr) Microbille d'hydrogel de chitosane
MA44909A (fr) Association thérapeutique d'un inhibiteur du cd19 et d'un inhibiteur de la btk
MA43113A (fr) Anticorps anti-htr a1 et méthodes d'utilisation de ceux-ci
FR2917292B1 (fr) Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
WO2019032945A9 (fr) Agent liant cd40 et utilisations associées
FR3081869B1 (fr) Monomeres monoethyleniquement insatures et leurs utilisations
FR3064633B1 (fr) Nouveaux composes de type dithiospirocetals et leur utilisation
MA38699A1 (fr) Formulation orale pour le traitement de maladies cardiovasculaires
FR3067592B1 (fr) Extrait de nœuds d'arbres appartenant au genre pinus comme fongicide
FR3082427B1 (fr) Combinaison de facteur vii et d'un anticorps bispecifique anti-facteurs ix et x
MA42006A1 (fr) Molécules hybrides